{"name":"Atavistik Bio, Inc","slug":"atavistik-bio-inc","ticker":"","exchange":"","domain":"atavistikbio.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ATV-1601","genericName":"ATV-1601","slug":"atv-1601","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ATV-1601","genericName":"ATV-1601","slug":"atv-1601","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPRWtpcVlQQ2xoMnJwaDFUa3F6eDhJQ2dqUmp6cnNYUk1mb3RfUWxIT3NMMGtxdXZMRERtWVBaNmFFZ1hYcWRJYkZfMmNLYmxrTS1kNnltc2k4S0ZfTWEyVUZ4VVd6dnVmZGoza2gxYUg2REd1RFN2dElRRFptUDdndENjaXVhQ0NOVXhSTTlIWlYzay1XR2FVSEJWcw?oc=5","date":"2026-03-06","type":"pipeline","source":"The Pharma Letter","summary":"Atavistik Bio closes $40 million Series B extension - The Pharma Letter","headline":"Atavistik Bio closes $40 million Series B extension","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNaW1oNlAxaHFBNGZnUS14TDdwTS1Oa250LVhfQTBwSnljMDJ6OE9wb0dwWmtLeHlsRVBFZGs2UW55dDdicjgySldwb2lzZEdPWXpSNHlETThHdTd2ZzM5d3EyTTB4cWJqdW91UjZPb2JNZzNtdVYzTS0xOV9yY0J0R01GYzRWMWR4aTRTUzR1SU5ncEJ2MXZDLXpB?oc=5","date":"2026-03-05","type":"pipeline","source":"BioPharma Dive","summary":"A startup making drugs for blood disorders banks $160M - BioPharma Dive","headline":"A startup making drugs for blood disorders banks $160M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBscWxrXzMtN041U2pvVDc4TE9ES1lBbHBzX2hJb2NLX05xVnlEVmY0MFNTSnNxNHdiUmlRdGt3YVdsOG1nMUM5SU5nV2x6TU1OZklB?oc=5","date":"2026-03-05","type":"pipeline","source":"FirstWord Pharma","summary":"Atavistik bags another $40M to advance drug for rare vascular disease - FirstWord Pharma","headline":"Atavistik bags another $40M to advance drug for rare vascular disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxPQ1lhRjI5TkRqWEMtZktNdmd6NFNvLWowOTNsdUFfOFpBOVVnNnRUemVxLTlfN09DcnQ2N2ZzRnI4dVBFa09CSzNuMFBSX0d5UGVZalVvcGFRNk5kN3dLdHNjMHF0d1o4WVJmejEzdmdpNG4zTkdqSDU3eUFTRk5laExza0ZWRXI4UUc5M2plN3ZSWFYzWk1ZT0hVSDFhNVo2c2R6OHZvNWdLdWlValpVQlRWWHM4Q0xNOXFkeTJTT3ltVUk3NTAyb2dxNmItQ3pUZDdZa2pLek1kSHpEa2ZpVWhnV2k3MzRRcjBCSHF0c1Y3U3A3M3NwbFVzamFoVF9uRlpJN1VTRmFJRTZfVFZBWmtxWlNJU2NxZ1dwZzQwZ1A0dkh6UHc?oc=5","date":"2026-03-05","type":"pipeline","source":"GlobeNewswire","summary":"Atavistik Bio Closes $40 Million Series B Extension for - GlobeNewswire","headline":"Atavistik Bio Closes $40 Million Series B Extension for","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOQkxmbk12TjRSRXhEVnFZTGotcy1sUlZsYXdPSTNBeV9BTk40QnJraDBzeHppNGpuR0JLVmk3TV82a0drdXhTdUpGOTgzMk5DbVdlclZYMTQzSzlfelE1eTdwYXpGVXBNMzV6eW05ZjBPLTFTMHF5TUNscEVlTkhqWQ?oc=5","date":"2025-12-19","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOWGc5WWRTZGM0ajNYXzMtRzgxN21DTjZWcHFoZ19jc2Y3UVR6VmFqUXFJYnk1Z2tXdWdyc2NWaEZIaFBISkpsdDZCXzQweWtLblFGR0JON05YUGllem1sdkFBWEVXa3ZLa2EydUU0d1o1ZlZ2VlBIaHBLd21DaHRjbkpaX25VRkd2TmdTbk0zZXptd2RkMms0bDRJMnR4WkxnSk9MekNrY05HcTRtOGJDM3oxcw?oc=5","date":"2025-12-19","type":"pipeline","source":"The Pharma Letter","summary":"Allosteric therapeutics co Atavistik Bio raises $120 million Series B - The Pharma Letter","headline":"Allosteric therapeutics co Atavistik Bio raises $120 million Series B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBYN0ZTU09USUdISDduYnd3bVJBWkJLZVZra3NfQWVyekhHeTBRaGhoWFJCNFNyNTEyYUhJUS16a3Fyell5WmJuSk14N05VcWhFd1VF?oc=5","date":"2025-12-18","type":"pipeline","source":"FirstWord Pharma","summary":"Regeneron backs Atavistik's $120M raise to advance small molecule pair - FirstWord Pharma","headline":"Regeneron backs Atavistik's $120M raise to advance small molecule pair","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxQdmV5eDhTb19meFdEWGhSSXAxdU1zZ0NKQVVKcktnX19pZ1RHN2dVWlFhTUd6MHc3cXRfSXBIc0ZTak9mU0JhRGZSa0xVRW9FUGh0dmtXNmU4U0FWS3pCank1U2pPc3BjTmtWYWZRaWxzS3FzenN1QkV3QnEwNXItQ21BV3k3Y0VnMTZjV0VZRzc4emltZ2R0TDV0ZU1DdnVQOGc1SUg1dXA0NEJ2ckoyWDVoSDg2OGVWUEt5RDQ0a0M5dEMzRlNLVzBPMVJOVUV0TEtaZkRfSl9XRmM2VTF5N0NiVTdhamI0Z1F5bi1KV1RHTVJMZGFLNmg0SjhyR2NJ?oc=5","date":"2025-09-15","type":"pipeline","source":"GlobeNewswire","summary":"Atavistik Bio Expands Leadership Team with Appointment of Susan Pandya, M.D., as Chief Medical Officer - GlobeNewswire","headline":"Atavistik Bio Expands Leadership Team with Appointment of Susan Pandya, M.D., as Chief Medical Officer","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}